PEBP1 Knockout HEK293 Cell Line
Cat.No.:
EDC07757
Species:
Human
Cell Name:
HEK293
Gene:
PEBP1
Gene ID:
5037
Size:
1×10⁶cells
PEBP1 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07757 |
|---|---|
| Product Name | PEBP1 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | PEBP1 |
| NCBI Gene ID | |
| Gene Synonyms | HCNP|HCNPpp|HEL-210|HEL-S-34|HEL-S-96|PBP|PEBP|PEBP-1|RKIP |
| Summary |
This gene encodes a member of the phosphatidylethanolamine-binding family of proteins and has been shown to modulate multiple signaling pathways, including the MAP kinase (MAPK), NF-kappa B, and glycogen synthase kinase-3 (GSK-3) signaling pathways. The encoded protein can be further processed to form a smaller cleavage product, hippocampal cholinergic neurostimulating peptide (HCNP), which may be involved in neural development. This gene has been implicated in numerous human cancers and may act as a metastasis suppressor gene. Multiple pseudogenes of this gene have been identified in the genome. [provided by RefSeq, Jul 2015]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying PEBP1 function, PEBP1 Knockout HEK293 Cell Line or PEBP1 overexpression HEK293 Cell Line?
The choice depends on whether you are studying PEBP1 (RKIP, Raf kinase inhibitor protein)'s role as a metastasis suppressor or its functions inhibiting Raf-MEK-ERK signaling and IKK/NF-κB pathways. The Knockout line is the standard tool for asking whether RKIP is required for these inhibitory functions — RKIP binds and inhibits Raf-1, MEK1, GRK2, and IKK, broadly attenuating proliferative and inflammatory signaling. Overexpression is useful for studying RKIP tumor suppressor functions in cancer contexts.
For cancer biology research, the EDITGENE PEBP1 Knockout in HEK293 enables study of Raf-MEK-ERK and NF-κB pathway hyperactivation following RKIP loss. Rescue with wild-type or phospho-RKIP-mimetic (S153D, which switches RKIP from Raf inhibition to GRK2 inhibition) enables comprehensive structure-function studies. RKIP loss is associated with metastatic progression in multiple cancers — the knockout serves as a tool for studying metastasis-permissive signaling networks.
What are the application scenarios for this model?
Primary applications:
• Raf-MEK-ERK pathway: phospho-MEK1/2 and phospho-ERK1/2 analysis to assess RKIP-mediated MAPK pathway attenuation in the absence of RKIP.
• NF-κB signaling: phospho-IKK, phospho-IκBα, and NF-κB target gene expression analysis given RKIP's IKK inhibition.
• GRK2-mediated GPCR desensitization: β-adrenergic receptor desensitization kinetics given RKIP's role in switching from Raf to GRK2 inhibition following S153 phosphorylation.
• Metastasis biology: invasion, migration, and EMT marker analysis given RKIP's role as a metastasis suppressor.
EDITGENE recommends this model for researchers investigating RKIP-mediated signaling attenuation, metastasis suppression mechanisms, and MAPK/NF-κB pathway regulation.
Is this PEBP1 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. RKIP rescue experiments are well-established for signaling research:
• Construct design: use a codon-modified PEBP1 sequence with a small C- or N-terminal tag (FLAG, HA). RKIP is small (~21 kDa) cytoplasmic protein — both tag positions are typically tolerated.
• Raf-binding-deficient rescue: specific residue mutations in the Raf-binding interface enable separating Raf inhibition from GRK2 inhibition.
• Phospho-mimetic rescue: S153D mutation mimics PKC-phosphorylated RKIP, switching from Raf to GRK2 inhibition — invaluable for studying RKIP's dual regulation.
• Functional readout: rescue should restore Raf-MEK-ERK pathway attenuation, NF-κB pathway inhibition, and metastasis suppressor phenotypes.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download